Browse Author Index

- A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

J

Meng, Jun

L

Meng, Lin

X

Meng, Xianlan

Y

Meng, Yajuan, Ning County Maternal and Child Health Hospital, Qingyang 745200, Gansu Province, China
Meng, Yanan, Department of Clinical Laboratory, Affiliated Hospital of Hebei University, Baoding 071000, Hebei Province, China

S

Miao, Shimin
Miao, Shuhang , Xinghua City People’s Hospital, Xinghua 225700, Jiangsu Province, China

X

Miao, Xiaona, Shaanxi University of Chinese Medicine, Xianyang 712046, Shaanxi Province, China

Y

Miao, Yudi , Department of Hematology, Shaanxi Provincial People's Hospital, Xi’an 710068, Shaanxi Province, China
Miao, Yudi , Department of Hematology, Shaanxi Provincial People’s Hospital, Xi’an 710068, China
Miao, Yudi , Department of Hematology, Shaanxi Provincial People’s Hospital, Xi’an 710068, Shaanxi Province, China
Miao, Yudi , [1] Lu S, Yao J, Li S, et al., 2021, Two Cases of Acute Non-Lymphocytic Leukemia with PICALM-MLLT10 and Literature Review. Chongqing Medicine, 50(19): 3369–3374. [2] Gao W, Jiang M, Gao L, et al., 2021, Analysis of Factors Related to Treatment Failure of Acute Lymphoblastic Leukemia in Children. Chinese Journal of Experimental Hematology, 29(03): 661–668. [3] Bai D, Bai Y, Tian F, 2021, Expression and Significance of Long Non-Coding RNA Homeobox Gene A11 Antisense RNA in the Bone Marrow of Children with Acute Lymphoblastic Leukemia. Cancer Progress, 19(20): 2087–2090. [4] Cao X, Wei Z, Liu D, et al., 2021, Comparison of the Efficacy of Haplotype and Sibling Hematopoietic Stem Cell Transplantation in the Treatment of Acute T-Lymphoblastic Leukemia in Complete Remission. Chinese Journal of Hematology, 42(03): 210–216. [5] Cao X, Qiu L, Zhang J, et al., 2021, Clinical Analysis of 41 Cases of Relapsed Acute B Lymphocytic Leukemia After CART Sequential Secondary Allogeneic Hematopoietic Stem Cell Transplantation. Chinese Journal of Hematology, 42(04): 318–323. [6] Zhang L, 2021, Changes of Peripheral Blood T Lymphocyte Subsets in Acute Myeloid Leukemia and Its Clinical Significance. Capital Food and Medicine, 28(17): 20–21. [7] Wang D, Ding Y, Zhou G, et al., 2021, Expression and Clinical Significance of Programmed Death Molecule 1/Programmed Death-Ligand 1 in Childhood Acute Lymphoblastic Leukemia. Chinese Journal of Practical Pediatrics, 36(07): 525–528. [8] Wang X, Chang Y, Liu Y, et al., 2021, Comparison of the Prognostic Significance of Minimal Residual Disease in Patients with PH-Positive Acute B Lymphoblastic Leukemia Before Allogeneic Hematopoietic Stem Cell Transplantation by Multiparameter Flow Cytometry and Real-Time PCR. Chin J Hematology, 42(02): 116–123. [9] Wang Z, Li S, Sun Y, et al., 2021, Positive Minimal Residual Disease Indicates Poor Prognosis of Acute Lymphoblastic Leukemia Patients with Complete Remission 2 or Above Before Allogeneic Transplantation. Chinese Journal of Laboratory Medicine, 44(12): 1145–1152. [10] Peng Q, Zhu C, Liu G, et al., 2021, Study on the Expression Significance of QKI, OCT4 and Bcl-2 mRNA in Children with Acute Lymphoblastic Leukemia. Chinese Journal of Cancer Prevention and Treatment, 28(15): 1151–1156. [11] Li L, Wang M, Song Y, et al., 2021, Application Value of ALL Multi-Probe System in the Diagnosis and Treatment of Childhood Acute Lymphoblastic Leukemia. Experimental and Laboratory Medicine, 39(02): 374–376. [12] Zhang X, Wang L, Tang B, et al., 2020, Pretreatment of Unrelated Umbilical Cord Blood Transplantation Without Antithymocyte Globulin for the Treatment of Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Follow-Up Evaluation of 306 Cases. Chinese Journal of Tissue Engineering Research, 24(31): 4986–4993. [13] Tang W, 2020, Analysis of the Relationship Between Adverse Reactions and Plasma Concentrations of High-Dose Methotrexate in the Treatment of Childhood Acute Lymphoblastic Leukemia. China Prescription Drugs, 18(12): 70–71. [14] Lv M, Jiang E, He Y, et al., 2020, Comparison of the Efficacy of Autologous and Sibling Hematopoietic Stem Cell Transplantation in the Treatment of Ph+ Acute Lymphoblastic Leukemia. Chinese Journal of Hematology, 41(05): 373–378. [15] Feng J, Zhang L, Cao X, et al., 2020, Treatment of Ph-Chromosome-Negative Adolescents and Young Adults with Acute Lymphoblastic Leukemia with a Similar Regimen for Children: A Single-Center Retrospective Study. Chinese Journal of Hematology, 41(05): 399–404.

G

Min, Geng

L

Min, Liu
Min, Liu, Department of Critical Care Medicine, The First Clinical Medical College of China Three Gorges University & Yichang Central People’s Hospital, Yichang 433000, Hubei Province, China

C

Ming, Chen

X

Ming, Xu

M

Mirteimouri, Masuomeh, Department of Obstetrics and Gynecology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

S

Mirzaeian, Sara, Department of Obstetrics and Gynecology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

M

Mofrad, Malihe Hasanzadeh, Department of Gynecology and Obstetrics, Mashhad University of Medical Sciences, Mashhad, Iran

J

Mou, Jie, The Sixth People’s Hospital of Yibin, Yibin 644000, Sichuan Province, China

Y

Mou, Yikun

Z

Mou, Zongyou

A

Mousa, Alaa, Hepatology Department, Ministry of Health, Egypt

S

MV, Shijina

51 - 75 of 75 items    << < 1 2 3